Next-generation sequencing - feasibility and practicality in haematology

British Journal of Haematology

Volumn 160, Issue 6, 2013, Pages 736-753

  Kohlmann, Alexander ^a   Grossmann, Vera ^a   Nadarajah, Niroshan ^a   Haferlach, Torsten ^a  

^a MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

Diagnostics; Gene panel; Leukaemia; Mutations; Next generation sequencing

Indexed keywords

MOLECULAR MARKER;

AMPLICON; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; GENETIC PROCEDURES; HEMATOLOGIC MALIGNANCY; HEMATOLOGY; HUMAN; MINIMAL RESIDUAL DISEASE; MUTATION; NEOPLASM; NEXT GENERATION SEQUENCING; PATIENT CODING; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW;

HEMATOLOGY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; SEQUENCE ANALYSIS, DNA;

EID: 84874735262     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12194     Document Type: Review

References (73)

1. Albert, T.J., Molla, M.N., Muzny, D.M., Nazareth, L., Wheeler, D., Song, X., Richmond, T.A., Middle, C.M., Rodesch, M.J., Packard, C.J., Weinstock, G.M. & Gibbs, R.A. (2007) Direct selection of human genomic loci by microarray hybridization. Nature Methods, 4, 903-905.
2. Bejar, R., Levine, R. & Ebert, B.L. (2011a) Unraveling the molecular pathophysiology of myelodysplastic syndromes. Journal of Clinical Oncology, 29, 504-515.
3. Bejar, R., Stevenson, K., bdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., Kantarjian, H., Raza, A., Levine, R.L., Neuberg, D. & Ebert, B.L. (2011b) Clinical effect of point mutations in myelodysplastic syndromes. New England Journal of Medicine, 364, 2496-2506.
4. Bentley, D.R., Balasubramanian, S., Swerdlow, H.P., Smith, G.P., Milton, J., Brown, C.G., Hall, K.P., Evers, D.J., Barnes, C.L., Bignell, H.R., Boutell, J.M., Bryant, J., Carter, R.J., Keira, C.R., Cox, A.J., Ellis, D.J., Flatbush, M.R., Gormley, N.A., Humphray, S.J., Irving, L.J., Karbelashvili, M.S., Kirk, S.M., Li, H., Liu, X., Maisinger, K.S., Murray, L.J., Obradovic, B., Ost, T., Parkinson, M.L., Pratt, M.R., Rasolonjatovo, I.M., Reed, M.T., Rigatti, R., Rodighiero, C., Ross, M.T., Sabot, A., Sankar, S.V., Scally, A., Schroth, G.P., Smith, M.E., Smith, V.P., Spiridou, A., Torrance, P.E., Tzonev, S.S., Vermaas, E.H., Walter, K., Wu, X., Zhang, L., Alam, M.D., Anastasi, C., Aniebo, I.C., Bailey, D.M., Bancarz, I.R., Banerjee, S., Barbour, S.G., Baybayan, P.A., Benoit, V.A., Benson, K.F., Bevis, C., Black, P.J., Boodhun, A., Brennan, J.S., Bridgham, J.A., Brown, R.C., Brown, A.A., Buermann, D.H., Bundu, A.A., Burrows, J.C., Carter, N.P., Castillo, N., Chiara, E., Catenazzi, M., Chang, S., Neil, C.R., Crake, N.R., Dada, O.O., Diakoumakos, K.D., Dominguez-Fernandez, B., Earnshaw, D.J., Egbujor, U.C., Elmore, D.W., Etchin, S.S., Ewan, M.R., Fedurco, M., Fraser, L.J., Fuentes Fajardo, K.V., Scott, F.W., George, D., Gietzen, K.J., Goddard, C.P., Golda, G.S., Granieri, P.A., Green, D.E., Gustafson, D.L., Hansen, N.F., Harnish, K., Haudenschild, C.D., Heyer, N.I., Hims, M.M., Ho, J.T., Horgan, A.M., Hoschler, K., Hurwitz, S., Ivanov, D.V., Johnson, M.Q., James, T., Huw Jones, T.A., Kang, G.D., Kerelska, T.H., Kersey, A.D., Khrebtukova, I. & Kindwall, A.P., Kingsbury, Z., Kokko-Gonzales, P.I., Kumar, A., Laurent, M.A., Lawley, C.T., Lee, S.E., Lee, X., Liao, A.K., Loch, J.A., Lok, M., Luo, S., Mammen, R.M., Martin, J.W., McCauley, P.G., McNitt, P., Mehta, P., Moon, K.W., Mullens, J.W., Newington, T., Ning, Z., Ling, N.B., Novo, S.M., O'Neill, M.J., Osborne, M.A., Osnowski, A., Ostadan, O., Paraschos, L.L., Pickering, L., Pike, A.C., Pike, A.C., Chris, P.D., Pliskin, D.P., Podhasky, J., Quijano, V.J., Raczy, C., Rae, V.H., Rawlings, S.R., Chiva, R.A., Roe, P.M., Rogers, J., Rogert Bacigalupo, M.C., Romanov, N., Romieu, A., Roth, R.K., Rourke, N.J., Ruediger, S.T., Rusman, E., Sanches-Kuiper, R.M., Schenker, M.R., Seoane, J.M., Shaw, R.J., Shiver, M.K., Short, S.W., Sizto, N.L., Sluis, J.P., Smith, M.A., Ernest Sohna, S.J., Spence, E.J., Stevens, K., Sutton, N., Szajkowski, L., Tregidgo, C.L., Turcatti, G., Vandevondele, S., Verhovsky, Y., Virk, S.M., Wakelin, S., Walcott, G.C., Wang, J., Worsley, G.J., Yan, J., Yau, L., Zuerlein, M., Rogers, J., Mullikin, J.C., Hurles, M.E., McCooke, N.J., West, J.S., Oaks, F.L., Lundberg, P.L., Klenerman, D., Durbin, R. & Smith, A.J. (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature, 456, 53-59.
5. Chapman, M.A., Lawrence, M.S., Keats, J.J., Cibulskis, K., Sougnez, C., Schinzel, A.C., Harview, C.L., Brunet, J.P., Ahmann, G.J., Adli, M., Anderson, K.C., Ardlie, K.G., Auclair, D., Baker, A., Bergsagel, P.L., Bernstein, B.E., Drier, Y., Fonseca, R., Gabriel, S.B., Hofmeister, C.C., Jagannath, S., Jakubowiak, A.J., Krishnan, A., Levy, J., Liefeld, T., Lonial, S., Mahan, S., Mfuko, B., Monti, S., Perkins, L.M., Onofrio, R., Pugh, T.J., Rajkumar, S.V., Ramos, A.H., Siegel, D.S., Sivachenko, A., Stewart, A.K., Trudel, S., Vij, R., Voet, D., Winckler, W., Zimmerman, T., Carpten, J., Trent, J., Hahn, W.C., Garraway, L.A., Meyerson, M., Lander, E.S., Getz, G. & Golub, T.R. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature, 471, 467-472.
6. Corey, S.J., Minden, M.D., Barber, D.L., Kantarjian, H., Wang, J.C. & Schimmer, A.D. (2007) Myelodysplastic syndromes: the complexity of stem-cell diseases. Nature Reviews Cancer, 7, 118-129.
7. Datta, S., Datta, S., Kim, S., Chakraborty, S. & Gill, R.S. (2010) Statistical analyses of next generation sequence data: a partial overview. Journal of Proteomics and Bioinformatics, 3, 183-190.
8. DeAngelis, M.M., Wang, D.G. & Hawkins, T.L. (1995) Solid-phase reversible immobilization for the isolation of PCR products. Nucleic Acids Research, 23, 4742-4743.
9. Delhommeau, F., Dupont, S., Della, V., James, C., Trannoy, S., Masse, A., Kosmider, O., le Couedic, J.P., Robert, F., Alberdi, A., Lecluse, Y., Plo, I., Dreyfus, F.J., Marzac, C., Casadevall, N., Lacombe, C., Romana, S.P., Dessen, P., Soulier, J., Viguie, F., Fontenay, M., Vainchenker, W. & Bernard, O.A. (2009) Mutation in TET2 in myeloid cancers. New England Journal of Medicine, 360, 2289-2301.
10. Dicker, F., Haferlach, C., Sundermann, J., Wendland, N., Weiss, T., Kern, W., Haferlach, T. & Schnittger, S. (2010) Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML. Leukemia, 24, 1528-1532.
11. Dietrich, S., Glimm, H., Andrulis, M., von, K.C., Ho, A.D. & Zenz, T. (2012) BRAF inhibition in refractory hairy-cell leukemia. New England Journal of Medicine, 366, 2038-2040.
12. Ding, L., Ley, T.J., Larson, D.E., Miller, C.A., Koboldt, D.C., Welch, J.S., Ritchey, J.K., Young, M.A., Lamprecht, T., McLellan, M.D., McMichael, J.F., Wallis, J.W., Lu, C., Shen, D., Harris, C.C., Dooling, D.J., Fulton, R.S., Fulton, L.L., Chen, K., Schmidt, H., Kalicki-Veizer, J., Magrini, V.J., Cook, L., McGrath, S.D., Vickery, T.L., Wendl, M.C., Heath, S., Watson, M.A., Link, D.C., Tomasson, M.H., Shannon, W.D., Payton, J.E., Kulkarni, S., Westervelt, P., Walter, M.J., Graubert, T.A., Mardis, E.R., Wilson, R.K. & Dipersio, J.F. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature, 481, 506-510.
13. Dolnik, A., Engelmann, J.C., Scharfenberger-Schmeer, M., Mauch, J., Kelkenberg-Schade, S., Haldemann, B., Fries, T., Kronke, J., Kuhn, M.W., Paschka, P., Kayser, S., Wolf, S., Gaidzik, V.I., Schlenk, R.F., Rucker, F.G., Dohner, H., Lottaz, C., Dohner, K. & Bullinger, L. (2012) Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing. Blood, 120, e83-e92.
14. Ecker, J.R., Bickmore, W.A., Barroso, I., Pritchard, J.K., Gilad, Y. & Segal, E. (2012) Genomics: ENCODE explained. Nature, 489, 52-55.
15. Ernst, T., Chase, A.J., Score, J., Hidalgo-Curtis, C.E., Bryant, C., Jones, A.V., Waghorn, K., Zoi, K., Ross, F.M., Reiter, A., Hochhaus, A., Drexler, H.G., Duncombe, A., Cervantes, F., Oscier, D., Boultwood, J., Grand, F.H. & Cross, N.C. (2010) Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat.Genet., 42, 722-726.
16. Fabbri, G., Rasi, S., Rossi, D., Trifonov, V., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S., Cresta, S., Gargiulo, E., Forconi, F., Guarini, A., Arcaini, L., Paulli, M., Laurenti, L., Larocca, L.M., Marasca, R., Gattei, V., Oscier, D., Bertoni, F., Mullighan, C.G., Foa, R., Pasqualucci, L., Rabadan, R., la-Favera, R. & Gaidano, G. (2011) Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. The Journal of Experimental Medicine, 208, 1389-1401.
17. Gelsi-Boyer, V., Trouplin, V., Adelaide, J., Bonansea, J., Cervera, N., Carbuccia, N., Lagarde, A., Prebet, T., Nezri, M., Sainty, D., Olschwang, S., Xerri, L., Chaffanet, M., Mozziconacci, M.J., Vey, N. & Birnbaum, D. (2009) Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. British Journal of Haematology, 145, 788-800.
18. Glenn, T.C. (2011) Field guide to next-generation DNA sequencers. Molecular Ecology Resources, 11, 759-769.
19. Gnirke, A., Melnikov, A., Maguire, J., Rogov, P., LeProust, E.M., Brockman, W., Fennell, T., Giannoukos, G., Fisher, S., Russ, C., Gabriel, S., Jaffe, D.B., Lander, E.S. & Nusbaum, C. (2009) Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nature Biotechnology, 27, 182-189.
20. Godley, L.A. (2012) Profiles in leukemia. New England Journal of Medicine, 366, 1152-1153.
21. Greenberg, P.L., Tuechler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Sole, F., Bennett, J.M., Bowen, D., Fenaux, P., Dreyfus, F., Kantarjian, H., Kuendgen, A., Levis, A., Malcovati, L., Cazzola, M., Cermak, J., Fonatsch, C., Le Beau, M.M., Slovak, M.L., Krieger, O., Luebbert, M., Maciejewski, J., Magalhaes, S.M., Miyazaki, Y., Pfeilstocker, M., Sekeres, M., Sperr, W.R., Stauder, R., Tauro, S., Valent, P., Vallespi, T., van de Loosdrecht, A.A., Germing, U. & Haase, D. (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood, 120, 2454-2465.
22. Grossmann, V., Kohlmann, A., Klein, H.U., Schindela, S., Schnittger, S., Dicker, F., Dugas, M., Kern, W., Haferlach, T. & Haferlach, C. (2011a) Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure. Leukemia, 25, 671-680.
23. Grossmann, V., Schnittger, S., Schindela, S., Klein, H.U., Eder, C., Dugas, M., Kern, W., Haferlach, T., Haferlach, C. & Kohlmann, A. (2011b) Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technology. Journal of Molecular Diagnostics, 13, 129-136.
24. Grossmann, V., Tiacci, E., Holmes, A.B., Kohlmann, A., Martelli, M.P., Kern, W., Spanhol-Rosseto, A., Klein, H.U., Dugas, M., Schindela, S., Trifonov, V., Schnittger, S., Haferlach, C., Bassan, R., Wells, V.A., Spinelli, O., Chan, J., Rossi, R., Baldoni, S., De, C.L., Goetze, K., Serve, H., Peceny, R., Kreuzer, K.A., Oruzio, D., Specchia, G., Di, R.F., Fabbiano, F., Sborgia, M., Liso, A., Farinelli, L., Rambaldi, A., Pasqualucci, L., Rabadan, R., Haferlach, T. & Falini, B. (2011c) Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood, 118, 6153-6163.
25. Grossmann, V., Kohlmann, A., Eder, C., Haferlach, C., Kern, W., Cross, N.C., Haferlach, T. & Schnittger, S. (2011d) Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia, 25, 877-879.
26. Grossmann, V., Schnittger, S., Kohlmann, A., Eder, C., Roller, A., Dicker, F., Schmid, C., Wendtner, C.M., Staib, P., Serve, H., Kreuzer, K.A., Kern, W., Haferlach, T. & Haferlach, C. (2012) A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood, 120, 2963-2972.
27. Harismendy, O., Schwab, R.B., Bao, L., Olson, J., Rozenzhak, S., Kotsopoulos, S.K., Pond, S., Crain, B., Chee, M.S., Messer, K., Link, D.R. & Frazer, K.A. (2011) Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing. Genome Biology, 12, R124.
28. Hoischen, A., van Bon, B.W., Gilissen, C., Arts, P., van Lier, B., Steehouwer, M., de Vries, P., de Reuver, R., Wieskamp, N., Mortier, G., Devriendt, K., Amorim, M.Z., Revencu, N., Kidd, A., Barbosa, M., Turner, A., Smith, J., Oley, C., Henderson, A., Hayes, I.M., Thompson, E.M., Brunner, H.G., de Vries, B.B. & Veltman, J.A. (2010) De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nature Genetics, 42, 483-485.
29. Jadersten, M., Saft, L., Smith, A., Kulasekararaj, A., Pomplun, S., Gohring, G., Hedlund, A., Hast, R., Schlegelberger, B., Porwit, A., Hellstrom-Lindberg, E. & Mufti, G.J. (2011) TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. Journal of Clinical Oncology, 29, 1971-1979.
30. Klein, H.U., Bartenhagen, C., Kohlmann, A., Grossmann, V., Ruckert, C., Haferlach, T. & Dugas, M. (2011) R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing data. Bioinformatics, 27, 1162-1163.
31. Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala, H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R., Liu, X.S., Aravind, L., Agarwal, S., Maciejewski, J.P. & Rao, A. (2010) Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature, 468, 839-843.
32. Kohlmann, A., Grossmann, V., Klein, H.U., Schindela, S., Weiss, T., Kazak, B., Dicker, F., Schnittger, S., Dugas, M., Kern, W., Haferlach, C. & Haferlach, T. (2010a) Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. Journal of Clinical Oncology, 28, 3858-3865.
33. Kohlmann, A., Grossmann, V., Schindela, S., Kern, W., Haferlach, C., Haferlach, T. & Schnittger, S. (2010b) Ultra-deep next-generation sequencing detects RUNX1 mutations with unprecedented sensitivity and allows to monitor minimal residual disease in 116 samples from MDS and AML patients clinically relevant abstract. Blood, 116, 1691a.
34. Kohlmann, A., Klein, H.U., Weissmann, S., Bresolin, S., Chaplin, T., Cuppens, H., Haschke-Becher, E., Garicochea, B., Grossmann, V., Hanczaruk, B., Hebestreit, K., Gabriel, C., Iacobucci, I., Jansen, J.H., Te, K.G., van de, L.L., Martinelli, G., McGowan, K., Schweiger, M.R., Timmermann, B., Vandenberghe, P., Young, B.D., Dugas, M. & Haferlach, T. (2011) The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories. Leukemia, 25, 1840-1848.
35. Kohlmann, A., Martinelli, G., Hofmann, W.-K., Kronnie, G., Chiaretti, S., Preudhomme, C., Tagliafico, E., Hernandez, J., Gabriel, C., Lion, T., Vandenberghe, P., Polakova, K.M., Béné, M.-C., Brueggemann, M., Cazzaniga, G., Yeoh, A., Lehmann, S., Ernst, T., Oppliger Leibundgut, E., Ozbek, U., Mills, K.I., Dugas, M., Thiede, C., Spinelli, O., Foroni, L., Jansen, J.H., Hochhaus, A. & Haferlach, T. (2012) The Interlaboratory Robustness of Next-generation sequencing (IRON) study phase II: deep-sequencing analyses of hematological malignancies performed by an international network involving 26 laboratories. Blood (ASH Annual Meeting Abstracts), 120, abstract 1399.
36. Koskela, H.L., Eldfors, S., Ellonen, P., van Adrichem, A.J., Kuusanmaki, H., Andersson, E.I., Lagstrom, S., Clemente, M.J., Olson, T., Jalkanen, S.E., Majumder, M.M., Almusa, H., Edgren, H., Lepisto, M., Mattila, P., Guinta, K., Koistinen, P., Kuittinen, T., Penttinen, K., Parsons, A., Knowles, J., Saarela, J., Wennerberg, K., Kallioniemi, O., Porkka, K., Loughran, T.P. Jr, Heckman, C.A., Maciejewski, J.P. & Mustjoki, S. (2012) Somatic STAT3 mutations in large granular lymphocytic leukemia. New England Journal of Medicine, 366, 1905-1913.
37. Ley, T.J., Mardis, E.R., Ding, L., Fulton, B., McLellan, M.D., Chen, K., Dooling, D., Dunford-Shore, B.H., McGrath, S., Hickenbotham, M., Cook, L., Abbott, R., Larson, D.E., Koboldt, D.C., Pohl, C., Smith, S., Hawkins, A., Abbott, S., Locke, D., Hillier, L.W., Miner, T., Fulton, L., Magrini, V., Wylie, T., Glasscock, J., Conyers, J., Sander, N., Shi, X., Osborne, J.R., Minx, P., Gordon, D., Chinwalla, A., Zhao, Y., Ries, R.E., Payton, J.E., Westervelt, P., Tomasson, M.H., Watson, M., Baty, J., Ivanovich, J., Heath, S., Shannon, W.D., Nagarajan, R., Walter, M.J., Link, D.C., Graubert, T.A., Dipersio, J.F. & Wilson, R.K. (2008) DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature, 456, 66-72.
38. Ley, T.J., Ding, L., Walter, M.J., McLellan, M.D., Lamprecht, T., Larson, D.E., Kandoth, C., Payton, J.E., Baty, J., Welch, J., Harris, C.C., Lichti, C.F., Townsend, R.R., Fulton, R.S., Dooling, D.J., Koboldt, D.C., Schmidt, H., Zhang, Q., Osborne, J.R., Lin, L., O'Laughlin, M., McMichael, J.F., Delehaunty, K.D., McGrath, S.D., Fulton, L.A., Magrini, V.J., Vickery, T.L., Hundal, J., Cook, L.L., Conyers, J.J., Swift, G.W., Reed, J.P., Alldredge, P.A., Wylie, T., Walker, J., Kalicki, J., Watson, M.A., Heath, S., Shannon, W.D., Varghese, N., Nagarajan, R., Westervelt, P., Tomasson, M.H., Link, D.C., Graubert, T.A., Dipersio, J.F., Mardis, E.R. & Wilson, R.K. (2010) DNMT3A mutations in acute myeloid leukemia. New England Journal of Medicine, 363, 2424-2433.
39. Li, M., Collins, R., Jiao, Y., Ouillette, P., Bixby, D., Erba, H., Vogelstein, B., Kinzler, K.W., Papadopoulos, N. & Malek, S.N. (2011) Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia. Blood, 118, 5914-5917.
40. Loman, N.J., Misra, R.V., Dallman, T.J., Constantinidou, C., Gharbia, S.E., Wain, J. & Pallen, M.J. (2012) Performance comparison of benchtop high-throughput sequencing platforms. Nature Biotechnology, 30, 434-439.
41. Mardis, E.R. & Wilson, R.K. (2009) Cancer genome sequencing: a review. Human etics, 18, R163-R168.
42. Mardis, E.R., Ding, L., Dooling, D.J., Larson, D.E., McLellan, M.D., Chen, K., Koboldt, D.C., Fulton, R.S., Delehaunty, K.D., McGrath, S.D., Fulton, L.A., Locke, D.P., Magrini, V.J., Abbott, R.M., Vickery, T.L., Reed, J.S., Robinson, J.S., Wylie, T., Smith, S.M., Carmichael, L., Eldred, J.M., Harris, C.C., Walker, J., Peck, J.B., Du, F., Dukes, A.F., Sanderson, G.E., Brummett, A.M., Clark, E., McMichael, J.F., Meyer, R.J., Schindler, J.K., Pohl, C.S., Wallis, J.W., Shi, X., Lin, L., Schmidt, H., Tang, Y., Haipek, C., Wiechert, M.E., Ivy, J.V., Kalicki, J., Elliott, G., Ries, R.E., Payton, J.E., Westervelt, P., Tomasson, M.H., Watson, M.A., Baty, J., Heath, S., Shannon, W.D., Nagarajan, R., Link, D.C., Walter, M.J., Graubert, T.A., Dipersio, J.F., Wilson, R.K. & Ley, T.J. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. New England Journal of Medicine, 361, 1058-1066.
43. Margulies, M., Egholm, M., Altman, W.E., Attiya, S., Bader, J.S., Bemben, L.A., Berka, J., Braverman, M.S., Chen, Y.J., Chen, Z., Dewell, S.B., Du, L., Fierro, J.M., Gomes, X.V., Godwin, B.C., He, W., Helgesen, S., Ho, C.H., Irzyk, G.P., Jando, S.C., Alenquer, M.L., Jarvie, T.P., Jirage, K.B., Kim, J.B., Knight, J.R., Lanza, J.R., Leamon, J.H., Lefkowitz, S.M., Lei, M., Li, J., Lohman, K.L., Lu, H., Makhijani, V.B., McDade, K.E., McKenna, M.P., Myers, E.W., Nickerson, E., Nobile, J.R., Plant, R., Puc, B.P., Ronan, M.T., Roth, G.T., Sarkis, G.J., Simons, J.F., Simpson, J.W., Srinivasan, M., Tartaro, K.R., Tomasz, A., Vogt, K.A., Volkmer, G.A., Wang, S.H., Wang, Y., Weiner, M.P., Yu, P., Begley, R.F. & Rothberg, J.M. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437, 376-380.
44. Meggendorfer, M., Roller, A., Haferlach, T., Eder, C., Dicker, F., Grossmann, V., Kohlmann, A., Alpermann, T., Yoshida, K., Ogawa, S., Koeffler, H.P., Kern, W., Haferlach, C. & Schnittger, S. (2012) SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood, 120, 3080-3088.
45. Metzker, M.L. (2010) Sequencing technologies - the next generation. Nature Reviews. Genetics, 11, 31-46.
46. Nikoloski, G., Langemeijer, S.M., Kuiper, R.P., Knops, R., Massop, M., Tonnissen, E.R., van der, H.A., Scheele, T.N., Vandenberghe, P., de, W.T., van der Reijden, B.A. & Jansen, J.H. (2010) Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nature Genetics, 42, 665-667.
47. Oscier, D.G., Rose-Zerilli, M.J., Winkelmann, N., Gonzalez de, C.D., Gomez, B., Forster, J., Parker, H., Parker, A., Gardiner, A., Collins, A., Else, M., Cross, N.C., Catovsky, D. & Strefford, J.C. (2012) The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood, doi: 10.1182/blood-2012-05-429282.
48. Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J.S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., Godfrey, A.L., Rapado, I., Cvejic, A., Rance, R., McGee, C., Ellis, P., Mudie, L.J., Stephens, P.J., McLaren, S., Massie, C.E., Tarpey, P.S., Varela, I., Nik-Zainal, S., Davies, H.R., Shlien, A., Jones, D., Raine, K., Hinton, J., Butler, A.P., Teague, J.W., Baxter, E.J., Score, J., Galli, A., la Porta, M.G., Travaglino, E., Groves, M., Tauro, S., Munshi, N.C., Anderson, K.C., El-Naggar, A., Fischer, A., Mustonen, V., Warren, A.J., Cross, N.C., Green, A.R., Futreal, P.A., Stratton, M.R. & Campbell, P.J. (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. New England Journal of Medicine, 365, 1384-1395.
49. Patel, J.P., Gonen, M., Figueroa, M.E., Fernandez, H., Sun, Z., Racevskis, J., Van, V.P., Dolgalev, I., Thomas, S., Aminova, O., Huberman, K., Cheng, J., Viale, A., Socci, N.D., Heguy, A., Cherry, A., Vance, G., Higgins, R.R., Ketterling, R.P., Gallagher, R.E., Litzow, M., van den Brink, M.R., Lazarus, H.M., Rowe, J.M., Luger, S., Ferrando, A., Paietta, E., Tallman, M.S., Melnick, A., bdel-Wahab, O. & Levine, R.L. (2012) Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. New England Journal of Medicine, 366, 1079-1089.
50. Puente, X.S., Pinyol, M., Quesada, V., Conde, L., Ordonez, G.R., Villamor, N., Escaramis, G., Jares, P., Bea, S., Gonzalez-Diaz, M., Bassaganyas, L., Baumann, T., Juan, M., Lopez-Guerra, M., Colomer, D., Tubio, J.M., Lopez, C., Navarro, A., Tornador, C., Aymerich, M., Rozman, M., Hernandez, J.M., Puente, D.A., Freije, J.M., Velasco, G., Gutierrez-Fernandez, A., Costa, D., Carrio, A., Guijarro, S., Enjuanes, A., Hernandez, L., Yague, J., Nicolas, P., Romeo-Casabona, C.M., Himmelbauer, H., Castillo, E., Dohm, J.C., de, S.S., Piris, M.A., de, A.E., San, M.J., Royo, R., Gelpi, J.L., Torrents, D., Orozco, M., Pisano, D.G., Valencia, A., Guigo, R., Bayes, M., Heath, S., Gut, M., Klatt, P., Marshall, J., Raine, K., Stebbings, L.A., Futreal, P.A., Stratton, M.R., Campbell, P.J., Gut, I., Lopez-Guillermo, A., Estivill, X., Montserrat, E., Lopez-Otin, C. & Campo, E. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature, 475, 101-105.
51. Quail, M.A., Smith, M., Coupland, P., Otto, T.D., Harris, S.R., Connor, T.R., Bertoni, A., Swerdlow, H.P. & Gu, Y. (2012) A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13, 341.
52. Quesada, V., Conde, L., Villamor, N., Ordonez, G.R., Jares, P., Bassaganyas, L., Ramsay, A.J., Bea, S., Pinyol, M., Martinez-Trillos, A., Lopez-Guerra, M., Colomer, D., Navarro, A., Baumann, T., Aymerich, M., Rozman, M., Delgado, J., Gine, E., Hernandez, J.M., Gonzalez-Diaz, M., Puente, D.A., Velasco, G., Freije, J.M., Tubio, J.M., Royo, R., Gelpi, J.L., Orozco, M., Pisano, D.G., Zamora, J., Vazquez, M., Valencia, A., Himmelbauer, H., Bayes, M., Heath, S., Gut, M., Gut, I., Estivill, X., Lopez-Guillermo, A., Puente, X.S., Campo, E. & Lopez-Otin, C. (2012) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nature Genetics, 44, 47-52.
53. Rothberg, J.M., Hinz, W., Rearick, T.M., Schultz, J., Mileski, W., Davey, M., Leamon, J.H., Johnson, K., Milgrew, M.J., Edwards, M., Hoon, J., Simons, J.F., Marran, D., Myers, J.W., Davidson, J.F., Branting, A., Nobile, J.R., Puc, B.P., Light, D., Clark, T.A., Huber, M., Branciforte, J.T., Stoner, I.B., Cawley, S.E., Lyons, M., Fu, Y., Homer, N., Sedova, M., Miao, X., Reed, B., Sabina, J., Feierstein, E., Schorn, M., Alanjary, M., Dimalanta, E., Dressman, D., Kasinskas, R., Sokolsky, T., Fidanza, J.A., Namsaraev, E., McKernan, K.J., Williams, A., Roth, G.T. & Bustillo, J. (2011) An integrated semiconductor device enabling non-optical genome sequencing. Nature, 475, 348-352.
54. Sayers, E.W., Barrett, T., Benson, D.A., Bolton, E., Bryant, S.H., Canese, K., Chetvernin, V., Church, D.M., Dicuccio, M., Federhen, S., Feolo, M., Fingerman, I.M., Geer, L.Y., Helmberg, W., Kapustin, Y., Landsman, D., Lipman, D.J., Lu, Z., Madden, T.L., Madej, T., Maglott, D.R., Marchler-Bauer, A., Miller, V., Mizrachi, I., Ostell, J., Panchenko, A., Phan, L., Pruitt, K.D., Schuler, G.D., Sequeira, E., Sherry, S.T., Shumway, M., Sirotkin, K., Slotta, D., Souvorov, A., Starchenko, G., Tatusova, T.A., Wagner, L., Wang, Y., Wilbur, W.J., Yaschenko, E. & Ye, J. (2011) Database resources of the National Center for Biotechnology Information. Nucleic Acids Research, 39, D38-D51.
55. Schnittger, S., Dicker, F., Kern, W., Wendland, N., Sundermann, J., Alpermann, T., Haferlach, C. & Haferlach, T. (2011) RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis. Blood, 117, 2348-2357.
56. Schnittger, S., Bacher, U., Haferlach, T., Wendland, N., Ulke, M., Dicker, F., Grossmann, V., Haferlach, C. & Kern, W. (2012a) Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia. Blood, 119, 3151-3154.
57. Schnittger, S., Eder, C., Jeromin, S., Alpermann, T., Fasan, A., Grossmann, V., Kohlmann, A., Illig, T., Klopp, N., Wichmann, H.E., Kreuzer, K.A., Schmid, C., Staib, P., Peceny, R., Schmitz, N., Kern, W., Haferlach, C. & Haferlach, T. (2012b) ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia, doi: 10.1038/leu.2012.262.
58. Teer, J.K., Bonnycastle, L.L., Chines, P.S., Hansen, N.F., Aoyama, N., Swift, A.J., Abaan, H.O., Albert, T.J., Margulies, E.H., Green, E.D., Collins, F.S., Mullikin, J.C. & Biesecker, L.G. (2010) Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Research, 20, 1420-1431.
59. Tewhey, R., Warner, J.B., Nakano, M., Libby, B., Medkova, M., David, P.H., Kotsopoulos, S.K., Samuels, M.L., Hutchison, J.B., Larson, J.W., Topol, E.J., Weiner, M.P., Harismendy, O., Olson, J., Link, D.R. & Frazer, K.A. (2009) Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nature Biotechnology, 27, 1025-1031.
60. Thomas, R.K., Nickerson, E., Simons, J.F., Janne, P.A., Tengs, T., Yuza, Y., Garraway, L.A., LaFramboise, T., Lee, J.C., Shah, K., O'Neill, K., Sasaki, H., Lindeman, N., Wong, K.K., Borras, A.M., Gutmann, E.J., Dragnev, K.H., DeBiasi, R., Chen, T.H., Glatt, K.A., Greulich, H., Desany, B., Lubeski, C.K., Brockman, W., Alvarez, P., Hutchison, S.K., Leamon, J.H., Ronan, M.T., Turenchalk, G.S., Egholm, M., Sellers, W.R., Rothberg, J.M. & Meyerson, M. (2006) Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nature Medicine, 12, 852-855.
61. Tiacci, E., Trifonov, V., Schiavoni, G., Holmes, A., Kern, W., Martelli, M.P., Pucciarini, A., Bigerna, B., Pacini, R., Wells, V.A., Sportoletti, P., Pettirossi, V., Mannucci, R., Elliott, O., Liso, A., Ambrosetti, A., Pulsoni, A., Forconi, F., Trentin, L., Semenzato, G., Inghirami, G., Capponi, M., Di, R.F., Patti, C., Arcaini, L., Musto, P., Pileri, S., Haferlach, C., Schnittger, S., Pizzolo, G., Foa, R., Farinelli, L., Haferlach, T., Pasqualucci, L., Rabadan, R. & Falini, B. (2011) BRAF mutations in hairy-cell leukemia. New England Journal of Medicine, 364, 2305-2315.
62. Tiacci, E., Grossmann, V., Martelli, M.P., Kohlmann, A., Haferlach, T. & Falini, B. (2012) The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia. Haematologica, 97, 3-5.
63. Treon, S.P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R.J., Patterson, C.J., Tripsas, C., Arcaini, L., Pinkus, G.S., Rodig, S.J., Sohani, A.R., Harris, N.L., Laramie, J.M., Skifter, D.A., Lincoln, S.E. & Hunter, Z.R. (2012) MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. New England Journal of Medicine, 367, 826-833.
64. Van Vlierberghe, P., Palomero, T., Khiabanian, H., Van der, M.J., Castillo, M., Van, R.N., De, M.B., Philippe, J., Gonzalez-Garcia, S., Toribio, M.L., Taghon, T., Zuurbier, L., Cauwelier, B., Harrison, C.J., Schwab, C., Pisecker, M., Strehl, S., Langerak, A.W., Gecz, J., Sonneveld, E., Pieters, R., Paietta, E., Rowe, J.M., Wiernik, P.H., Benoit, Y., Soulier, J., Poppe, B., Yao, X., Cordon-Cardo, C., Meijerink, J., Rabadan, R., Speleman, F. & Ferrando, A. (2010) PHF6 mutations in T-cell acute lymphoblastic leukemia. Nature Genetics, 42, 338-342.
65. Vissers, L.E., de, L.J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., van Bon, B.W., Hoischen, A., de Vries, B.B., Brunner, H.G. & Veltman, J.A. (2010) A de novo paradigm for mental retardation. Nature Genetics, 42, 1109-1112.
66. Voelkerding, K.V., Dames, S. & Durtschi, J.D. (2010) Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. Journal of Molecular Diagnostics, 12, 539-551.
67. Walter, M.J., Shen, D., Ding, L., Shao, J., Koboldt, D.C., Chen, K., Larson, D.E., McLellan, M.D., Dooling, D., Abbott, R., Fulton, R., Magrini, V., Schmidt, H., Kalicki-Veizer, J., O'Laughlin, M., Fan, X., Grillot, M., Witowski, S., Heath, S., Frater, J.L., Eades, W., Tomasson, M., Westervelt, P., Dipersio, J.F., Link, D.C., Mardis, E.R., Ley, T.J., Wilson, R.K. & Graubert, T.A. (2012) Clonal architecture of secondary acute myeloid leukemia. New England Journal of Medicine, 366, 1090-1098.
68. Wang, L., Lawrence, M.S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D.S., Zhang, L., Zhang, W., Vartanov, A.R., Fernandes, S.M., Goldstein, N.R., Folco, E.G., Cibulskis, K., Tesar, B., Sievers, Q.L., Shefler, E., Gabriel, S., Hacohen, N., Reed, R., Meyerson, M., Golub, T.R., Lander, E.S., Neuberg, D., Brown, J.R., Getz, G. & Wu, C.J. (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. New England Journal of Medicine, 365, 2497-2506.
69. Welch, J.S., Ley, T.J., Link, D.C., Miller, C.A., Larson, D.E., Koboldt, D.C., Wartman, L.D., Lamprecht, T.L., Liu, F., Xia, J., Kandoth, C., Fulton, R.S., McLellan, M.D., Dooling, D.J., Wallis, J.W., Chen, K., Harris, C.C., Schmidt, H.K., Kalicki-Veizer, J.M., Lu, C., Zhang, Q., Lin, L., O'Laughlin, M.D., McMichael, J.F., Delehaunty, K.D., Fulton, L.A., Magrini, V.J., McGrath, S.D., Demeter, R.T., Vickery, T.L., Hundal, J., Cook, L.L., Swift, G.W., Reed, J.P., Alldredge, P.A., Wylie, T.N., Walker, J.R., Watson, M.A., Heath, S.E., Shannon, W.D., Varghese, N., Nagarajan, R., Payton, J.E., Baty, J.D., Kulkarni, S., Klco, J.M., Tomasson, M.H., Westervelt, P., Walter, M.J., Graubert, T.A., Dipersio, J.F., Ding, L., Mardis, E.R. & Wilson, R.K. (2012) The origin and evolution of mutations in acute myeloid leukemia. Cell, 150, 264-278.
70. Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., Chalkidis, G., Suzuki, Y., Shiosaka, M., Kawahata, R., Yamaguchi, T., Otsu, M., Obara, N., Sakata-Yanagimoto, M., Ishiyama, K., Mori, H., Nolte, F., Hofmann, W.K., Miyawaki, S., Sugano, S., Haferlach, C., Koeffler, H.P., Shih, L.Y., Haferlach, T., Chiba, S., Nakauchi, H., Miyano, S. & Ogawa, S. (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature, 478, 64-69.
71. Zenz, T., Eichhorst, B., Busch, R., Denzel, T., Habe, S., Winkler, D., Buhler, A., Edelmann, J., Bergmann, M., Hopfinger, G., Hensel, M., Hallek, M., Dohner, H. & Stilgenbauer, S. (2010) TP53 mutation and survival in chronic lymphocytic leukemia. Journal of Clinical Oncology, 28, 4473-4479.
72. Zernant, J., Schubert, C., Im, K.M., Burke, T., Brown, C.M., Fishman, G.A., Tsang, S.H., Gouras, P., Dean, M. & Allikmets, R. (2011) Analysis of the ABCA4 gene by next-generation sequencing. Investigative Ophthalmology and Visual Science, 52, 8479-8487.
73. Zhao, Q., Kirkness, E.F., Caballero, O.L., Galante, P.A., Parmigiani, R.B., Edshall, L., Kuan, S., Ye, Z., Levy, S., Vasconcelos, A.T., Ren, B., de Souza, S.J., Camargo, A.A., Simpson, A.J. & Strausberg, R.L. (2010) Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing. Genome Biology, 11, R114.